BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lin Y, Kuo J, Hsu C, Tsai W, Li W, Yu M, Wen H. Optimizing manufacture of liposomal berberine with evaluation of its antihepatoma effects in a murine xenograft model. International Journal of Pharmaceutics 2013;441:381-8. [DOI: 10.1016/j.ijpharm.2012.11.017] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Behl T, Singh S, Sharma N, Zahoor I, Albarrati A, Albratty M, Meraya AM, Najmi A, Bungau S. Expatiating the Pharmacological and Nanotechnological Aspects of the Alkaloidal Drug Berberine: Current and Future Trends. Molecules 2022;27:3705. [PMID: 35744831 DOI: 10.3390/molecules27123705] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Liu Y, Nwafor E, Li Z, Wang J, Feng X, Li H, Jia B, Ma H, He J, Pi J, Liu Z. Effects of Berberine on Liver Cancer. Natural Product Communications 2022;17:1934578X2211020. [DOI: 10.1177/1934578x221102032] [Reference Citation Analysis]
3 Apiratikul N, Sriklung K, Dolsophon K, Thamvapee P, Watanapokasin R, Yingyongnarongkul B, Niyomtham N, Bremner JB, Watanavetch P, Samosorn S. Enhancing Anticancer Potency of a 13-Substituted Berberine Derivative with Cationic Liposomes. Chem Pharm Bull (Tokyo) 2022. [PMID: 35342147 DOI: 10.1248/cpb.c21-01049] [Reference Citation Analysis]
4 Mahmoud K, Swidan S, El-nabarawi M, Teaima M. Lipid based nanoparticles as a novel treatment modality for hepatocellular carcinoma: a comprehensive review on targeting and recent advances. J Nanobiotechnol 2022;20. [DOI: 10.1186/s12951-022-01309-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Bhasin J, Thakur B, Kumar S, Chopra V. Tree Turmeric: A Super Food and Contemporary Nutraceutical of 21st Century - A Laconic Review. J Am Coll Nutr 2021;:1-19. [PMID: 34757887 DOI: 10.1080/07315724.2021.1958104] [Reference Citation Analysis]
6 Loh JS, Tan LKS, Lee WL, Ming LC, How CW, Foo JB, Kifli N, Goh BH, Ong YS. Do Lipid-based Nanoparticles Hold Promise for Advancing the Clinical Translation of Anticancer Alkaloids? Cancers (Basel) 2021;13:5346. [PMID: 34771511 DOI: 10.3390/cancers13215346] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Singh S, Pathak N, Fatima E, Negi AS. Plant isoquinoline alkaloids: Advances in the chemistry and biology of berberine. Eur J Med Chem 2021;226:113839. [PMID: 34536668 DOI: 10.1016/j.ejmech.2021.113839] [Cited by in F6Publishing: 20] [Reference Citation Analysis]
8 Malhotra B, Kulkarni GT, Dhiman N, Joshi D, Chander S, Kharkwal A, Sharma AK, Kharkwal H. Recent advances on Berberis aristata emphasizing berberine alkaloid including phytochemistry, pharmacology and drug delivery system. Journal of Herbal Medicine 2021;27:100433. [DOI: 10.1016/j.hermed.2021.100433] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
9 Šudomová M, Berchová-Bímová K, Marzocco S, Liskova A, Kubatka P, Hassan STS. Berberine in Human Oncogenic Herpesvirus Infections and Their Linked Cancers. Viruses 2021;13:1014. [PMID: 34071559 DOI: 10.3390/v13061014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
10 Rahman M, Almalki WH, Alrobaian M, Iqbal J, Alghamdi S, Alharbi KS, Alruwaili NK, Hafeez A, Shaharyar A, Singh T, Waris M, Kumar V, Beg S. Nanocarriers-loaded with natural actives as newer therapeutic interventions for treatment of hepatocellular carcinoma. Expert Opin Drug Deliv 2021;18:489-513. [PMID: 33225771 DOI: 10.1080/17425247.2021.1854223] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
11 Mandlik DS, Mandlik SK. Herbal and Natural Dietary Products: Upcoming Therapeutic Approach for Prevention and Treatment of Hepatocellular Carcinoma. Nutr Cancer 2020;:1-25. [PMID: 33073617 DOI: 10.1080/01635581.2020.1834591] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
12 Zhou M, Deng Y, Liu M, Liao L, Dai X, Guo C, Zhao X, He L, Peng C, Li Y. The pharmacological activity of berberine, a review for liver protection. Eur J Pharmacol 2021;890:173655. [PMID: 33068590 DOI: 10.1016/j.ejphar.2020.173655] [Cited by in F6Publishing: 17] [Reference Citation Analysis]
13 Kumar S, Fayaz F, Pottoo FH, Bajaj S, Manchanda S, Bansal H. Nanophytomedicine Based Novel Therapeutic Strategies in Liver Cancer. CTMC 2020;20:1999-2024. [DOI: 10.2174/1568026619666191114113048] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Ping Z, Jun X, Yan W, Jun Z. Anti-cancer properties of specific Chinese herbal medicines for hepatocellular carcinoma treatment. Eur J Integr Med 2020;:101215. [PMID: 33042292 DOI: 10.1016/j.eujim.2020.101215] [Reference Citation Analysis]
15 Majidzadeh H, Araj-khodaei M, Ghaffari M, Torbati M, Ezzati Nazhad Dolatabadi J, Hamblin MR. Nano-based delivery systems for berberine: A modern anti-cancer herbal medicine. Colloids and Surfaces B: Biointerfaces 2020;194:111188. [DOI: 10.1016/j.colsurfb.2020.111188] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
16 Tousi MS, Sepehri H, Khoee S, Farimani MM, Delphi L, Mansourizadeh F. Evaluation of apoptotic effects of mPEG-b-PLGA coated iron oxide nanoparticles as a eupatorin carrier on DU-145 and LNCaP human prostate cancer cell lines. J Pharm Anal 2021;11:108-21. [PMID: 33717617 DOI: 10.1016/j.jpha.2020.04.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
17 Habtemariam S. Recent Advances in Berberine Inspired Anticancer Approaches: From Drug Combination to Novel Formulation Technology and Derivatization. Molecules 2020;25:E1426. [PMID: 32245062 DOI: 10.3390/molecules25061426] [Cited by in Crossref: 11] [Cited by in F6Publishing: 20] [Article Influence: 5.5] [Reference Citation Analysis]
18 Paşcalău V, Bogdan C, Pall E, Matroş L, Pandrea S, Suciu M, Borodi G, Iuga CA, Ştiufiuc R, Topală T, Pavel C, Popa C, Moldovan ML. Development of BSA gel/Pectin/Chitosan polyelectrolyte complex microcapsules for Berberine delivery and evaluation of their inhibitory effect on Cutibacterium acnes. Reactive and Functional Polymers 2020;147:104457. [DOI: 10.1016/j.reactfunctpolym.2019.104457] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
19 Mortazavi H, Nikfar B, Esmaeili SA, Rafieenia F, Saburi E, Chaichian S, Heidari Gorji MA, Momtazi-Borojeni AA. Potential cytotoxic and anti-metastatic effects of berberine on gynaecological cancers with drug-associated resistance. Eur J Med Chem 2020;187:111951. [PMID: 31821990 DOI: 10.1016/j.ejmech.2019.111951] [Cited by in Crossref: 10] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
20 Jia J, Zhang K, Zhou X, Ma J, Liu X, Xiang A, Ge F. Berberine-loaded solid proliposomes prepared using solution enhanced dispersion by supercritical CO2: Sustained release and bioavailability enhancement. Journal of Drug Delivery Science and Technology 2019;51:356-63. [DOI: 10.1016/j.jddst.2019.03.021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
21 Chen M, Zhou X, Chen R, Wang J, Ye RD, Wang Y, Wu C, Mahato RI. Nano-carriers for delivery and targeting of active ingredients of Chinese medicine for hepatocellular carcinoma therapy. Materials Today 2019;25:66-87. [DOI: 10.1016/j.mattod.2018.10.040] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
22 Hermawan A, Putri H. Current report of natural product development against breast cancer stem cells. The International Journal of Biochemistry & Cell Biology 2018;104:114-32. [DOI: 10.1016/j.biocel.2018.09.012] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
23 Zheng X, Wu F, Lin X, Shen L, Feng Y. Developments in drug delivery of bioactive alkaloids derived from traditional Chinese medicine. Drug Deliv 2018;25:398-416. [PMID: 29378456 DOI: 10.1080/10717544.2018.1431980] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
24 Mirhadi E, Rezaee M, Malaekeh-nikouei B. Nano strategies for berberine delivery, a natural alkaloid of Berberis. Biomedicine & Pharmacotherapy 2018;104:465-73. [DOI: 10.1016/j.biopha.2018.05.067] [Cited by in Crossref: 59] [Cited by in F6Publishing: 67] [Article Influence: 14.8] [Reference Citation Analysis]
25 Elsheikh MA, Elnaggar YSR, Otify DY, Abdallah OY. Bioactive-Chylomicrons for Oral Lymphatic Targeting of Berberine Chloride: Novel Flow-Blockage Assay in Tissue-Based and Caco-2 Cell Line Models. Pharm Res 2018;35. [DOI: 10.1007/s11095-017-2307-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
26 Elsheikh MA, Elnaggar YS, Hamdy DA, Abdallah OY. Novel cremochylomicrons for improved oral bioavailability of the antineoplastic phytomedicine berberine chloride: Optimization and pharmacokinetics. International Journal of Pharmaceutics 2018;535:316-24. [DOI: 10.1016/j.ijpharm.2017.11.023] [Cited by in Crossref: 29] [Cited by in F6Publishing: 39] [Article Influence: 7.3] [Reference Citation Analysis]
27 Rizwanullah M, Amin S, Mir SR, Fakhri KU, Rizvi MMA. Phytochemical based nanomedicines against cancer: current status and future prospects. Journal of Drug Targeting 2018;26:731-52. [DOI: 10.1080/1061186x.2017.1408115] [Cited by in Crossref: 23] [Cited by in F6Publishing: 33] [Article Influence: 4.6] [Reference Citation Analysis]
28 Al-Awady MJ, Fauchet A, Greenway GM, Paunov VN. Enhanced antimicrobial effect of berberine in nanogel carriers with cationic surface functionality. J Mater Chem B 2017;5:7885-97. [PMID: 32264390 DOI: 10.1039/c7tb02262j] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 5.8] [Reference Citation Analysis]
29 Wang X, Wang Q, Liu Z, Zheng X. Preparation, pharmacokinetics and tumour-suppressive activity of berberine liposomes. Journal of Pharmacy and Pharmacology 2017;69:625-32. [DOI: 10.1111/jphp.12692] [Cited by in Crossref: 12] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
30 Subramanian AP, Jaganathan SK, Manikandan A, Pandiaraj KN, N G, Supriyanto E. Recent trends in nano-based drug delivery systems for efficient delivery of phytochemicals in chemotherapy. RSC Adv 2016;6:48294-314. [DOI: 10.1039/c6ra07802h] [Cited by in Crossref: 58] [Cited by in F6Publishing: 60] [Article Influence: 9.7] [Reference Citation Analysis]
31 Shi C, Cao H, He W, Gao F, Liu Y, Yin L. Novel drug delivery liposomes targeted with a fully human anti-VEGF165 monoclonal antibody show superior antitumor efficacy in vivo. Biomedicine & Pharmacotherapy 2015;73:48-57. [DOI: 10.1016/j.biopha.2015.05.008] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]